Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Estrella Immunopharma, Inc. (ESLA) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Estrella Immunopharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1844417.
Total stock buying since 2022: $44,677,961,594.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 2,100 | $2,594 | 0 | $0 | 0 | $0 |
| 2022 | 141,970 | $44,677,959,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-10 | 1,000 | $1,330 | 0 | $0 | 0 | $0 |
| 2025-09 | 1,100 | $1,264 | 0 | $0 | 0 | $0 |
| 2022-03 | 141,970 | $44,677,959,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-10-07 | Xu Jiandong (Chief Financial Officer) | Buy | 1,000 | 1.33 | 1,330 |
| 2025-09-22 | Xu Jiandong (Chief Financial Officer) | Buy | 1,000 | 1.16 | 1,160 |
| 2025-09-11 | Xu Jiandong (Chief Financial Officer) | Buy | 100 | 1.04 | 104 |
| 2022-03-04 | Li Jianwei (Co-Chief Executive Officer) | Buy | 141,970 | 314,700.00 | 44,677,959,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ESLA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Estrella Immunopharma, Inc. (symbol ESLA, CIK number 1844417) see the Securities and Exchange Commission (SEC) website.